MODB | ZFIN | Morpholino Index | Advance Search | BLAST Search | About MODB
Search By For Use * as a wildcard character (e.g. "BMP*"). For Tips on search see Search FAQs.
Morpholino Summary
General Information
Morpholino name: SP3007    
Morpholino sequence: CACATCACCATACCTTCTCAGTGGA
Find in Genbank
Target name: nbl1
Target sequence: (Morpholino Target and ATG)
Search in Genbank Search in Ensembl
TGAGAGAGTGTGTGTGATGTAATTGTTTAACTTCAGCAGGTCATAAGAGGGCGACGCGTCCGTTAATCAGCATCTGAGATCCGTCAGCGGGACGTCACACACACACACACACACACACACACACACAGACAGACACAGACGCTCCACACACACCGCGAGCTGCTAATCCACTGAGAAGGTATGGTGATGTGTGTGCGCGCGGTGCTGGTGTGTGTGCTGCTGGAGCTGAGCCGCGCTGCTCCACACGCGCACATCAACCGACTCGCGCTGTTTCCCGATAAAAGTGCCTGGTGTGAGGCCAAAAACATCACGCAGATCGTCGGACACACCGGCTGCACGCCACGATCCATCCAAAACAGGGCATGTCTGGGTCAGTGCTTCAGCTACAGTGTACCCAACACCTTCCCACAATCCACTGAGTCTCTGGTGCACTGTGACTCCTGCATGCCGGCGCAGACGCAGTGGGAAGTGGTGACTCTGGACTGCTCAGGCAGTGATGAAGCTCCGCGTGTGGATAAGTTAGTGGAGCGTATCCTGCACTGCAGCTGCCAGTCCTGCAGTAAAGAGAGCAGCCAGGAGGGGGCGCTGCTGCAGCTGTACCCTCATGAGGGAGCCCAGGACTTGCCATCACTGCCCGATGCCACACACACACACCCCCAGCACGCTCACATGCAAGCAGACCAAAGAGATGCAGACGCACATTTAGACATGCACGCGCCCGAGGCTGGGTGAAACACACACACACACGCACATGCTTTACACAGCCTACTGAACACTCTCCCTCTTCCTAAAGCACTTTCCTCACAACACTAATCAATACTTCAAGAATAAATGCGCTCACATTTGCAACTATATATTACTAGCTTTGTTTCTATTTTATGCACATTGTGGAATATTGCATACAATATTAATGGAAATACACATTAAAAACGATTAGACTTGGATAAACATTTGTCTGATAAGGAATAAACTCTGCTGTATACAGCTGTAGTAAGTAAACTC
Gene targeted:
neuroblastoma, suppression of tumorigenicity 1
Find in ZFIN Find in Pubmed
All the morpholinos targets to the gene
Synonyms:
Comments:
Reference:

Survival Curve: Normality Curve:
Note: When more than one data point existed per dose an average was used. p53 morpholino co-injections were used to minimize non-specific toxicity effects (Robu et al. PLoS Genetics 2007)
Screens Performed (number of tests): Defects Observed:
Skin: (1)
Pituitary: (2)
Kidney: (4)
Eye: (7)
Vasculature: (7)
Pigment: (8)
- pigment cells [propose more pigmetation]
(78.57%, dose:9ng, p53:13.5ng, days: -)
- eye dysplastic
(10%, dose:9ng, p53:13.5ng, days: -)
- eye medial
(10%, dose:9ng, p53:13.5ng, days: -)
- iridophores decreased number
(12.5%, dose:9ng, p53:13.5ng, days: -)
- tail coiled
(11.76%, dose:9ng, p53:13.5ng, days: -)
- dorsal aorta [proposed pooling]
(14.29%, dose:12ng, p53:18ng, days: -)
- pigment cells [propose more pigmetation]
(71.43%, dose:12ng, p53:18ng, days: -)
- tail short length
(25%, dose:12ng, p53:18ng, days: -)

Images